Predicting factors for non-suicidal self-injury in patients with schizophrenia spectrum disorders and the role of substance use.


Journal

Asian journal of psychiatry
ISSN: 1876-2026
Titre abrégé: Asian J Psychiatr
Pays: Netherlands
ID NLM: 101517820

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 09 12 2019
revised: 31 03 2020
accepted: 01 04 2020
pubmed: 7 5 2020
medline: 22 6 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

Non-suicidal self-injury (NSSI) has been shown as a characteristic feature in many clinical populations in recent years and schizophrenia is one of the most common psychiatric disorders which is associated with NSSI. In this study, we aimed to investigate predictors of NSSI in patients with schizophrenia spectrum disorders (SSD) and the role of lifetime substance use disorder (SUD). A sample of 165 patients with a diagnosis of SSD who were in remission participated in the study. Lifetime NSSI was assessed using the Inventory of Statements About Self-injury (ISAS). Lifetime SUD were evaluated. Logistic regression analysis was conducted to predict NSSI. SUD was found to be related to NSSI in patients with SSD, and it was associated with an approximately fourfold increase in the risk of NSSI. The rates of lifetime SUD in our sample and in the NSSI (+) group were 38.2 % and 55.6 %, respectively. The most commonly abused substances among patients with NSSI were cannabis and synthetic cannabinoids. The prevalence of NSSI was 43.6 % in our sample. 'Self-cutting' was the most common type and 'affect regulation' was the most common function of NSSI. One of the most significant risk factors for NSSI was a previous history of suicide attempts. SUD appears to be a significant predictor of NSSI in patients with SSD. Further investigation of treatable risk factors such as SUD which are related to NSSI is needed. It is also essential to screen SSD patients for NSSI due to the probable relation to high risk of suicide.

Identifiants

pubmed: 32371364
pii: S1876-2018(20)30179-9
doi: 10.1016/j.ajp.2020.102068
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102068

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Erengül Güney (E)

Bakırköy Prof. Mazhar Osman Training and Research Hospital for Psychiatry and Neurology, Bakırköy, İstanbul, 34280, Turkey. Electronic address: erenguney@outlook.com.

İzgi Alnıak (İ)

Bakırköy Prof. Mazhar Osman Training and Research Hospital for Psychiatry and Neurology, Bakırköy, İstanbul, 34280, Turkey.

Murat Erkıran (M)

Bakırköy Prof. Mazhar Osman Training and Research Hospital for Psychiatry and Neurology, Bakırköy, İstanbul, 34280, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH